Cellergy Pharma Inc.

Wilmington, DE

UEI
LXM4AFNZRND1
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
200 Powder Mill Rd Bldg 500, Wilmington, DE 19803, USA
Website
cellergypharma.com
Founded
2022
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Bispecific antibody targeting IGE-producing b cells for treating allergic diseases R41AI188995 National Institute of Allergy and Infectious Diseases (NIH) $594,407
Chimeric antigen receptor (car) t cell therapy for severe allergic diseases. R41AI177157 National Institute of Allergy and Infectious Diseases (NIH) $300,000

Quick answers

Is Cellergy Pharma Inc. registered in SAM.gov?

Yes. Cellergy Pharma Inc.'s SAM.gov registration is active through March 1, 2027.

What is Cellergy Pharma Inc.'s most recent federal award?

Cellergy Pharma Inc.'s most recent federal grant award is Bispecific antibody targeting IGE-producing b cells for treating allergic diseases (R41AI188995), from National Institute of Allergy and Infectious Diseases (NIH), on February 1, 2025.

On GovTribe

See Cellergy Pharma Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login